Jaguar Health (JAGX) executive Chaturvedi acquired 134 shares

Insider transactions reported

Pravin R Chaturvedi (Chief Scientific Officer at Jaguar Health Inc., JAGX) reported that they acquired 134 shares on Apr 5, 2024. After these transactions the filing shows 1,270 shares held directly.

Reporting person

Chaturvedi Pravin R

Role

Chief Scientific Officer

Options and other derivatives

Holdings before and after

• Common Stock: 1,136 to 1,270 direct
• Restricted stock units: 134 to 0 direct

Footnotes from the filing

1. 1. Restricted stock units convert into common stock on a one-for-one basis.
2. 2. On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the September 2021 Reverse Stock Split ). Upon effectiveness of the September 2021 Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
3. 3. The restricted stock units were previously reported as covering 30,000 shares, but were adjusted to reflect the September 2021 Reverse Stock Split and January 2023 Reverse Stock Split. Such restricted stock units were granted on April 5, 2021 and vest in three equal annual installments beginning on April 5, 2022, the first anniversary of the grant date.

Transaction codes in this filing

Exercise or conversion of a derivative:

Code M marks the exercise or conversion of an option or other derivative under an exempt plan.

FAQ